Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

US Approved Rx

12

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Cyclooxygenase

12

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

12

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1974

12

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Backache

12

Common cold

12

Headache

12

Muscular aches

12

Toothache

12

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Palliative

12

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Penetrant

12

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Adams, S. at Boots Pure Drug

12

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

12

All Match

Any Match

Exclude Selected

Exclude Selected

INN Stem

Chemical substance(-ine)

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

12

FDA UNII

12

PUBCHEM

12

EPA CompTox

9

SMS_ID

8

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

CARDIOVASCULAR SYSTEM

1

GENITO URINARY SYSTEM AND SEX HORMONES

1

MUSCULO-SKELETAL SYSTEM

1

NERVOUS SYSTEM

1

RESPIRATORY SYSTEM

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

ANALGESICS

1

ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS

1

CARDIAC THERAPY

1

OTHER GYNECOLOGICALS

1

THROAT PREPARATIONS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS

1

OPIOIDS

1

OTHER CARDIAC PREPARATIONS

1

OTHER GYNECOLOGICALS

1

THROAT PREPARATIONS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Antiinflammatory preparations, non-steroids for topical use

1

Antiinflammatory products for vaginal administration

1

Opioids in combination with non-opioid analgesics

1

Other cardiac preparations

1

Other throat preparations

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Salts, Hydrates, Esters, etc.

11

Principal Form

1

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 11 - 12 of 12 results

First page
Previous page
2
Next page disabled
Next page disabled

IBUPROFEN LYSINE

N01ORX9D6S

Export Data
Search for Structure

Status:

US Approved Rx (2020)

First approved in 1974

Class (Stereo):

CHEMICAL (EPIMERIC)

Targets:

Conditions:

Ibuprofen is a nonsteroidal anti-inflammatory agent (NSAIA) or nonsteroidal anti-inflammatory drug (NSAID), with analgesic and antipyretic properties. Ibuprofen has pharmacologic actions similar to those of other prototypical NSAIAs, which are though...

t to act through inhibition of prostaglandin synthesis. It’s used temporarily relieves minor aches and pains due to: headache; the common cold; muscular aches; backache; toothache; minor pain of arthritis; menstrual cramps and temporarily reduces fever. The exact mechanism of action of ibuprofen is unknown. Ibuprofen is a non-selective inhibitor of cyclooxygenase, an enzyme invovled in prostaglandin synthesis via the arachidonic acid pathway. Its pharmacological effects are believed to be due to inhibition cylooxygenase-2 (COX-2) which decreases the synthesis of prostaglandins involved in mediating inflammation, pain, fever and swelling. Antipyretic effects may be due to action on the hypothalamus, resulting in an increased peripheral blood flow, vasodilation, and subsequent heat dissipation. Inhibition of COX-1 is thought to cause some of the side effects of ibuprofen including GI ulceration. Ibuprofen is administered as a racemic mixture. The R-enantiomer undergoes extensive interconversion to the S-enantiomer in vivo. The S-enantiomer is believed to be the more pharmacologically active enantiomer.

IBUPROFEN PICONOL

B0F91K5U4N

Export Data
Search for Structure

Status:

US Approved Rx (2020)

First approved in 1974

Class (Stereo):

CHEMICAL (RACEMIC)

Targets:

Conditions:

Ibuprofen is a nonsteroidal anti-inflammatory agent (NSAIA) or nonsteroidal anti-inflammatory drug (NSAID), with analgesic and antipyretic properties. Ibuprofen has pharmacologic actions similar to those of other prototypical NSAIAs, which are though...

t to act through inhibition of prostaglandin synthesis. It’s used temporarily relieves minor aches and pains due to: headache; the common cold; muscular aches; backache; toothache; minor pain of arthritis; menstrual cramps and temporarily reduces fever. The exact mechanism of action of ibuprofen is unknown. Ibuprofen is a non-selective inhibitor of cyclooxygenase, an enzyme invovled in prostaglandin synthesis via the arachidonic acid pathway. Its pharmacological effects are believed to be due to inhibition cylooxygenase-2 (COX-2) which decreases the synthesis of prostaglandins involved in mediating inflammation, pain, fever and swelling. Antipyretic effects may be due to action on the hypothalamus, resulting in an increased peripheral blood flow, vasodilation, and subsequent heat dissipation. Inhibition of COX-1 is thought to cause some of the side effects of ibuprofen including GI ulceration. Ibuprofen is administered as a racemic mixture. The R-enantiomer undergoes extensive interconversion to the S-enantiomer in vivo. The S-enantiomer is believed to be the more pharmacologically active enantiomer.

Showing 11 - 12 of 12 results

First page
Previous page
2
Next page disabled
Next page disabled

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1